[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100577616":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":29,"centralContacts":34,"locations":44,"responsibleParty":61,"collaborators":10,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":10,"eligibilityCriteria":69,"healthyVolunteers":65,"sex":70,"minAge":71,"maxAge":10,"enrollmentInfo":72,"targetDuration":75,"studyType":76,"phases":10,"briefSummary":77,"conditions":78,"keywords":84,"overallStatus":46,"whyStopped":10,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"retrospective cohort",null,"In this cohort data will be recorded retrospectively",[13,14],"Drug: Oncologic drugs administered for treatment of breast cancer","Drug: Oncologic drug administered for treatment of gynecologic cancer",{"label":16,"type":10,"description":17,"interventionNames":18},"prospective cohort","In this cohort data will be recorded prospectively",[13,14],[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":10},"DRUG","Oncologic drugs administered for treatment of breast cancer","Data on oncologic drugs administered for treatment of breast cancer will be recorded",[16,9],{"type":21,"name":26,"description":27,"armGroupLabels":28,"otherNames":10},"Oncologic drug administered for treatment of gynecologic cancer","Data on oncologic drugs administered for treatment of gynecologic cancer will be recorded",[16,9],[30],{"name":31,"affiliation":32,"role":33},"Claudio Zamagni, MD","IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola","PRINCIPAL_INVESTIGATOR",[35,40],{"name":31,"role":36,"phone":37,"phoneExt":38,"email":39},"CONTACT","0512144548","0039","zamagniclaudio.sper@aosp.bo.it",{"name":41,"role":36,"phone":42,"phoneExt":38,"email":43},"Cinzia Pizzirani, PhD","0512144447","cinzia.pizzirani@aosp.bo.it",[45],{"facility":5,"status":46,"city":47,"state":10,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"RECRUITING","Bologna","40138","Italy","IT",{"type":52,"coordinates":53},"Point",[54,55],11.33875,44.49381,{"lat":55,"lon":54},[58,59],{"name":31,"role":36,"phone":37,"phoneExt":38,"email":39},{"name":41,"role":36,"phone":60,"phoneExt":38,"email":43},"2144447",{"type":62,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100577616","evaluating-efficacy-and-tolerability-of-anticancer-drug-therapies-for-the-treatment-of-gynecologic-and-breast-cancers-100577616",false,"NCT06800612","Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers","Observational Study Evaluating the Efficacy and Tolerability of Anticancer Drug Therapies Adopted for the Treatment of Gynecologic and Breast Cancers in Clinical Practice Compared with the Results of Registration Studies","Inclusion Criteria:\n\n* Diagnosis of histologically confirmed breast cancer or gynecological cancer, either early stage or metastatic;\n* Patients who have received treatment for breast cancer or gynecologic cancer since January 2010;\n* Any patient currently living and actually contactable must sign an informed consent to the study and processing of personal data.\n\nExclusion Criteria:\n\n* no exclusion criteria","ALL","18 Years",{"count":73,"type":74},100,"ESTIMATED","1 Year","OBSERVATIONAL","retrospective\u002Fprospective observational study. Objective of the study is to evaluate the effect of drugs in terms of objective responses, disease-free survival (DFS), progression-free survival (PFS), overall survival (OS), and side effects compared with registry studies in the medical therapy of breast and gynecologic cancers.",[79,80,81,82,83],"Breast Cancer Early Stage Breast Cancer (Stage 1-3)","Breast Cancer Metastatic","Ovarian Cancer","Cervical Carcinoma","Endometrial Cancer",[85,86,87,88,89,90],"observational","breast cancer","gynecologic cancer","ovarian cancer","cervical carcinoma","endometrial cancer","2025-01-28",{"date":93,"type":94},"2025-01-30","ACTUAL",{"date":96,"type":94},"2024-03-22",{"date":98,"type":74},"2030-12-31",{"name":5,"class":6},1]